Monash IVF Group Limited (MVF.AX)

AUD 1.08

(3.86%)

Operating Expenses Summary of Monash IVF Group Limited

Monash IVF Group Limited's latest annual operating expenses in 2024 was 91.1 Million AUD , up 221.11% from previous year.
Monash IVF Group Limited's latest quarterly operating expenses in 2024 FY was 32.9 Million AUD , up 15.97% from previous quarter.
Monash IVF Group Limited reported a annual operating expenses of 28.37 Million AUD in annual operating expenses 2023, up 7.82% from previous year.
Monash IVF Group Limited reported a annual operating expenses of 26.31 Million AUD in annual operating expenses 2022, up 16.75% from previous year.
Monash IVF Group Limited reported a quarterly operating expenses of 32.9 Million AUD for 2024 FY, up 15.97% from previous quarter.
Monash IVF Group Limited reported a quarterly operating expenses of 17.58 Million AUD for 2024 Q2, up 18.78% from previous quarter.

Annual Operating Expenses Chart of Monash IVF Group Limited (2024 - 2013)

Historical Annual Operating Expenses of Monash IVF Group Limited (2024 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2024	91.1 Million AUD	221.11%
2023	28.37 Million AUD	7.82%
2022	26.31 Million AUD	16.75%
2021	22.54 Million AUD	5.15%
2020	21.43 Million AUD	-0.59%
2019	21.56 Million AUD	-19.85%
2018	26.9 Million AUD	12.24%
2017	23.97 Million AUD	-2.41%
2016	24.56 Million AUD	40.07%
2015	17.53 Million AUD	-44.79%
2014	31.76 Million AUD	183.62%
2013	11.19 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q4	67.65 Million AUD	284.73%
2024 FY	32.9 Million AUD	15.97%
2024 Q2	17.58 Million AUD	18.78%
2023 Q4	14.8 Million AUD	9.12%
2023 Q2	13.56 Million AUD	-2.58%
2023 FY	28.37 Million AUD	7.82%
2022 Q2	12.38 Million AUD	1.93%
2022 Q4	13.92 Million AUD	12.44%
2022 FY	26.31 Million AUD	16.75%
2021 FY	22.54 Million AUD	5.15%
2021 Q2	10.31 Million AUD	0.21%
2021 Q4	12.15 Million AUD	17.83%
2020 Q4	10.29 Million AUD	-7.67%
2020 FY	21.43 Million AUD	-0.59%
2020 Q2	11.14 Million AUD	-7.99%
2019 Q2	11.85 Million AUD	-29.93%
2019 FY	21.56 Million AUD	-19.85%
2019 Q4	12.11 Million AUD	2.16%
2018 Q4	16.92 Million AUD	69.5%
2018 FY	26.9 Million AUD	12.24%
2018 Q2	9.98 Million AUD	-34.66%
2017 Q2	8.69 Million AUD	-41.38%
2017 FY	23.97 Million AUD	-2.41%
2017 Q4	15.28 Million AUD	75.77%
2016 FY	24.56 Million AUD	40.07%
2016 Q4	14.82 Million AUD	52.33%
2016 Q2	9.73 Million AUD	-0.97%
2015 Q4	9.82 Million AUD	27.55%
2015 FY	17.53 Million AUD	-44.79%
2015 Q2	7.7 Million AUD	-68.0%
2014 Q2	7.67 Million AUD	370.63%
2014 FY	31.76 Million AUD	183.62%
2014 Q4	24.08 Million AUD	213.74%
2013 Q4	1.63 Million AUD	-87.29%
2013 FY	11.19 Million AUD	0.0%
2013 Q2	12.83 Million AUD	0.0%

Peer Operating Expenses Comparison of Monash IVF Group Limited

Name	Operating Expenses	Operating Expenses Difference
Australian Clinical Labs Limited	81.54 Million AUD	-11.726%
BCAL Diagnostics Limited	8.54 Million AUD	-966.19%
Genetic Signatures Limited	4.3 Million AUD	-2014.879%
Genetic Technologies Limited	3.9 Million AUD	-2233.451%
Healius Limited	265.1 Million AUD	65.632%
Imagion Biosystems Limited	15.53 Million AUD	-486.496%
Integral Diagnostics Limited	61.88 Million AUD	-47.214%
INOVIQ Ltd	6.8 Million AUD	-1238.502%
Microba Life Sciences Limited	5.9 Million AUD	-1442.801%
Rhythm Biosciences Limited	5.34 Million AUD	-1603.014%
Sonic Healthcare Limited	1.49 Billion AUD	93.909%